WHO and RDIF this week will discuss a timetable for the next steps to evaluate the Sputnik V vaccine 
This week the World Health Organization (WHO ) will meet with the Russian Direct Investment Fund (RDIF) to discuss a timetable for the next steps to evaluate the Russian Sputnik V coronavirus vaccine as part of the Emergency Use Listing (EUL) procedure. This was reported to TASS at the WHO headquarters in Geneva.
The organization recalled that in October RDIF “signed all the necessary legal agreements necessary for the assessment under the EUL.” This step is a “prerequisite for all applicants.” In addition, on the way to the recognition of the drug, the Russian side must provide updated information on “corrective and preventive measures (CAPAs)” related to inspections at enterprises. As soon as the application and all materials are received and considered, “the applicant will be given a decision on the need for an on-site verification inspection,” added the WHO.
Related materials00: 01 – November 12 
“There will always be dissent” Some Russians deny the coronavirus and do not want to be vaccinated. How to convince them? 12:50 – November 11 
COVID passports, green passes and QR codes. using electronic certificates
On Friday, November 12, WHO Assistant Director-General Marianjela Simao announced that the organization intends to hold a meeting on Sputnik V this week. She noted that WHO “has questions on inspection at the N.F. Gamaleya National Research Center for Epidemiology and Microbiology, on production inspection.”
»Would be a positive step on the part of WHO, as it could facilitate the adoption of the drug worldwide. In particular, the diplomatic mission commented on the possible inclusion of the vaccine in the register of funds for use in emergency situations.